Schneider Taina, Kuussaari Kristiina, Virtanen Petri
University of Vaasa, Finnish Institute for Health and Welfare, Helsinki, Finland.
Finnish Institute for Health and Welfare, Helsinki, Finland.
Nordisk Alkohol Nark. 2023 Oct;40(5):424-442. doi: 10.1177/14550725231157503. Epub 2023 Jun 22.
To explore the goals and outcomes of public procurement of drug treatment services in OECD countries. The study explores how these complex services are procured and delivered. A systematic review of the literature (1990-2020) identified four partly overlapping models of drug treatment service procurement that are here labelled traditional, value-based, outcome-based, and innovative. Even though different forms of drug treatment services procurement are common, only 12 empirical studies that focused on procurement were found. The four models differ in their approaches to design and performance specifications and the role of competition and collaboration in the co-creation of value. Competition and incentives improve neither the efficiency nor the quality or the outcomes of complex drug treatment services. Whereas many studies focus on payment mechanisms, there are important research gaps that relate to the co-creation of value with and for the service-users and other stakeholders.
探索经合组织国家药品治疗服务公共采购的目标和成果。该研究探讨了这些复杂服务是如何采购和提供的。对文献（1990 - 2020年）进行的系统综述确定了药品治疗服务采购的四种部分重叠的模式，这里分别称为传统模式、基于价值的模式、基于结果的模式和创新模式。尽管不同形式的药品治疗服务采购很常见，但仅发现了12项专注于采购的实证研究。这四种模式在设计方法、绩效规范以及竞争与合作在价值共创中的作用方面存在差异。竞争和激励措施既不能提高复杂药品治疗服务的效率，也不能提升其质量或改善结果。虽然许多研究关注支付机制，但在与服务使用者及其他利益相关者共同创造价值方面仍存在重要的研究空白。
